These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19158153)

  • 1. Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study.
    Baumhäkel M; Müller U; Böhm M
    Eur J Heart Fail; 2009 Mar; 11(3):299-303. PubMed ID: 19158153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
    Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
    J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
    Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
    Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the management of heart failure in primary care.
    Calvert MJ; Shankar A; McManus RJ; Ryan R; Freemantle N
    Fam Pract; 2009 Apr; 26(2):145-53. PubMed ID: 19153098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guideline compliance in the treatment of patients with chronic heart failure through family doctor-centred health care: results of an evaluation study].
    Roehl I; Beyer M; Gondan M; Rochon J; Bauer E; Kaufmann-Kolle P; Gerlach FM
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(6):394-402. PubMed ID: 24075681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure.
    Watz R; Ekstrand AB; Engelbrektson V; Beermann B
    Eur J Clin Pharmacol; 2005 May; 61(3):209-14. PubMed ID: 15761755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry.
    De Blois J; Fagerland MW; Grundtvig M; Semb AG; Gullestad L; Westheim A; Hole T; Atar D; Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):31-6. PubMed ID: 27533962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines?
    Tomaszuk-Kazberuk A; Kozuch M; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Musial WJ
    Ren Fail; 2013; 35(2):235-42. PubMed ID: 23176538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy.
    Peters-Klimm F; Müller-Tasch T; Schellberg D; Remppis A; Barth A; Holzapfel N; Jünger J; Herzog W; Szecsenyi J
    Clin Res Cardiol; 2008 Apr; 97(4):244-52. PubMed ID: 18046524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey.
    de Groote P; Isnard R; Assyag P; Clerson P; Ducardonnet A; Galinier M; Jondeau G; Leurs I; Thébaut JF; Komajda M
    Eur J Heart Fail; 2007 Dec; 9(12):1205-11. PubMed ID: 18023249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.
    Komajda M; Lapuerta P; Hermans N; Gonzalez-Juanatey JR; van Veldhuisen DJ; Erdmann E; Tavazzi L; Poole-Wilson P; Le Pen C
    Eur Heart J; 2005 Aug; 26(16):1653-9. PubMed ID: 15827061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
    Hirt MN; Muttardi A; Helms TM; van den Bussche H; Eschenhagen T
    Clin Res Cardiol; 2016 May; 105(5):441-50. PubMed ID: 26552905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence Retention Trial (HART).
    Calvin JE; Shanbhag S; Avery E; Kane J; Richardson D; Powell L
    Congest Heart Fail; 2012; 18(2):73-8. PubMed ID: 22432552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
    Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of evidence-based medication use on long-term survival in patients hospitalised for heart failure in Western Australia.
    Teng TH; Hung J; Finn J
    Med J Aust; 2010 Mar; 192(6):306-10. PubMed ID: 20230346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of guideline-recommended therapies for heart failure in the Medicare population.
    DiMartino LD; Shea AM; Hernandez AF; Curtis LH
    Clin Cardiol; 2010 Jul; 33(7):400-5. PubMed ID: 20641116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
    Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS
    Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
    Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
    Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.